MONTE ROSA THERAPEUTICS INC (GLUE) Stock Balance Sheet
NASDAQ:GLUE - US61225M1027 - Common Stock
5 USD
+0.08 (+1.63%)
5 USD
0 (0%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 69.43M | 224.25M | 128.10M | 262.80M | 346.10M | |||
| Marketable Securities | 221.16M | 147.90M | 104.31M | N/A | N/A | |||
| Receivables | 2.37M | 173.00K | 505.00K | 7.70M | N/A | |||
| Other Current Assets | 6.50M | 5.12M | 3.29M | 5.40M | 2.60M | |||
| Total Current Assets | 299.46M | 377.44M | 236.21M | 275.90M | 348.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 54.73M | 56.31M | 62.61M | 61.90M | 12.30M | |||
| Other Non-Current Assets | 5.39M | 4.98M | 4.93M | 4.60M | 5.30M | |||
| Total Non-Current Assets | 60.12M | 61.29M | 67.54M | 66.50M | 17.60M | |||
| TOTAL ASSETS | 359.59M | 438.73M | 303.75M | 342.40M | 366.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 17.86M | 22.50M | 17.76M | 17.70M | 10.10M | |||
| Accounts Payable | 5.58M | 17.21M | 11.15M | 7.90M | 6.60M | |||
| Other Current Liabilities | 18.41M | 117.23M | 17.68M | N/A | 0.00 | |||
| Total Current Liabilities | 41.85M | 156.95M | 46.59M | 25.60M | 16.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 49.65M | 58.85M | 77.91M | 45.40M | 2.20M | |||
| Total Non-Current Liabilities | 49.65M | 58.85M | 77.91M | 45.40M | 2.20M | |||
| TOTAL LIABILITIES | 91.51M | 215.80M | 124.50M | 71.00M | 18.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -404.00M | -438.59M | -365.89M | -230.50M | -122.00M | |||
| Additional Paid In Capital | 675.45M | 664.87M | 547.86M | 503.70M | 471.60M | |||
| Common Shares | 6.00K | 6.00K | 5.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -3.37M | -3.36M | -2.72M | -1.80M | -2.00M | |||
| Shares Outstanding | 61.72M | 61.51M | 50.14M | 49.30M | 46.50M | |||
| Tangible Book Value per Share | 4.34 | 3.62 | 3.58 | 5.51 | 7.47 | |||
| Total Shareholders' Equity | 268.08M | 222.94M | 179.25M | 271.40M | 347.50M | |||
| TOTAL LIABILITIES AND EQUITY | 359.59M | 438.73M | 303.75M | 342.40M | 366.30M | |||
| Statistics | ||||||||
| Current Ratio | 7.16 | 2.40 | 5.07 | 10.78 | 21.01 | |||
| Return On Assets (ROA) | 6.72% | -16.57% | -44.56% | -31.69% | -20.19% | |||
| Return On Equity (ROE) | 9.02% | -32.61% | -75.51% | -39.98% | -21.28% | |||
| Return On Invested Capital (ROIC) | 3.72% | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 43.54% | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 43.54% | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21